Genetix Biotherapeutics
Return to all Congress Materials

Foundation for Sickle Cell Disease Research (FSCDR)

2021 Scientific Meeting

Materials

1

Products

Lyfgenia

Featured Posters & Presentations

PosterLyfgenia

Updated Results from the HGB-206 Group C Study of LentiGlobin for sickle cell disease gene therapy.

Authors: Krishnamurti L.